Dynamic Technology Lab Private LTD Kala Pharmaceuticals, Inc. Transaction History

Dynamic Technology Lab Private LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.16 - $2.74 $23,478 - $55,457	-20,240 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$2.62 - $5.43 $6,054 - $12,548	2,311 Added 12.89%	20,240 $53,000
Q2 2021 Aug 13, 2021	SELL	$5.06 - $8.15 $1,573 - $2,534	-311 Reduced 1.71%	17,929 $95,000
Q1 2021 May 14, 2021	SELL	$6.24 - $9.58 $152,412 - $233,991	-24,425 Reduced 57.25%	18,240 $123,000
Q4 2020 Feb 11, 2021	BUY	$6.28 - $8.79 $60,438 - $84,594	9,624 Added 29.13%	42,665 $289,000

Q3 2020 Nov 13, 2020	SELL	$7.5 - $11.11 $457 - $677	-61 Reduced 0.18%	33,041 $248,000
Q2 2020 Aug 14, 2020	BUY	$8.33 - $13.79 $275,739 - $456,476	33,102 New	33,102 $348,000

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $9.82M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.